Life Sciences IPOs Take a Breather December 02, 2013 | Press Release
Booming IPO Market Improving M&A Terms for Private Biotechs November 01, 2013 | Press Release
ADMA Biologics, Inc. Announces Pricing October 18, 2013 | Press ReleaseSee all News
Burrill & Company also works with major life science companies to spin out internal assets and capitalize on their value, ranging from the outright sale of products or businesses to the creation of new companies to exploit these assets. Burrill uses its extensive network to help companies to identify, assess and capture (“spin-in”) products and companies strategic to building their businesses.